Friedberg Ezra M, a director at Pelthos Therapeutics Inc. ($PTHS), sold shares on the open market four times in the last year, totaling about $280 thousand. His most recent sale occurred on November 25, 2025. These sales rank 7,700th among nearly 12,000 insiders in our database, where the average is $8.6 million across about 6.4 transactions per person. Friedberg made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 13, 2024 | Pelthos Therapeutics Inc. | $PTHS | Friedberg Ezra M | Director | A | Common Stock | 2454 | $0.00 | 185,549.0000 | 0 | 1.34% | 0.00% |
| June 14, 2024 | Pelthos Therapeutics Inc. | $PTHS | Friedberg Ezra M | Director | A | Common Stock | 6450 | $0.00 | 183,095.0000 | 0 | 3.65% | 0.00% |
| July 2, 2025 | Pelthos Therapeutics Inc. | $PTHS | Friedberg Ezra M | Director | A | Common Stock | 19108 | $0.00 | 204,657.0000 | 6,103,813 | 10.30% | 0.31% |
| Nov. 25, 2025 | Pelthos Therapeutics Inc. | $PTHS | Friedberg Ezra M | Director | S | Common Stock | 5999 | $28.00 | 128,574.0000 | 3,061,681 | 4.46% | 0.20% |
| Nov. 25, 2025 | Pelthos Therapeutics Inc. | $PTHS | Friedberg Ezra M | Director | S | Common Stock | 2000 | $28.14 | 126,574.0000 | 3,061,681 | 1.56% | 0.07% |
| Nov. 25, 2025 | Pelthos Therapeutics Inc. | $PTHS | Friedberg Ezra M | Director | S | Common Stock | 1 | $28.50 | 126,573.0000 | 3,061,681 | 0.00% | 0.00% |
| Nov. 25, 2025 | Pelthos Therapeutics Inc. | $PTHS | Friedberg Ezra M | Director | S | Common Stock | 2000 | $28.01 | 124,573.0000 | 3,061,681 | 1.58% | 0.07% |
| July 2, 2025 | Pelthos Therapeutics Inc. | $PTHS | Friedberg Ezra M | Director | A | Stock Option | 58230 | $0.00 | 58,230.0000 | 6,103,813 | 9999.99% | 0.95% |
| July 2, 2025 | Pelthos Therapeutics Inc. | $PTHS | Friedberg Ezra M | Director | A | Restricted Stock Units | 19108 | $0.00 | 28,012.0000 | 6,103,813 | 214.60% | 0.31% |
| July 1, 2025 | Pelthos Therapeutics Inc. | $PTHS | Friedberg Ezra M | Director | C | Common Stock | 40000 | $10.00 | 134,573.0000 | 6,103,813 | 42.30% | 0.66% |
| July 1, 2025 | Pelthos Therapeutics Inc. | $PTHS | Friedberg Ezra M | Director | C | Common Stock | 40000 | $10.00 | 134,573.0000 | 6,103,813 | 42.30% | 0.66% |
| July 1, 2025 | Pelthos Therapeutics Inc. | $PTHS | Friedberg Ezra M | Director | P | Series A Convertible Preferred Stock | 40000 | $0.00 | 40,000.0000 | 6,103,813 | 9999.99% | 0.66% |
| July 1, 2025 | Pelthos Therapeutics Inc. | $PTHS | Friedberg Ezra M | Director | P | Series A Convertible Preferred Stock | 40000 | $0.00 | 40,000.0000 | 6,103,813 | 9999.99% | 0.66% |
| July 1, 2025 | Pelthos Therapeutics Inc. | $PTHS | Friedberg Ezra M | Director | C | Series A Convertible Preferred Stock | 40000 | $0.00 | 0.0000 | 6,103,813 | 100.00% | 0.66% |
| July 1, 2025 | Pelthos Therapeutics Inc. | $PTHS | Friedberg Ezra M | Director | C | Series A Convertible Preferred Stock | 40000 | $0.00 | 0.0000 | 6,103,813 | 100.00% | 0.66% |
| Nov. 13, 2024 | Pelthos Therapeutics Inc. | $PTHS | Friedberg Ezra M | Director | A | Restricted Stock Units | 24533 | $0.00 | 634,752.0000 | 0 | 4.02% | 0.00% |
| June 14, 2024 | Pelthos Therapeutics Inc. | $PTHS | Friedberg Ezra M | Director | A | Restricted Stock Units | 64498 | $0.00 | 610,219.0000 | 0 | 11.82% | 0.00% |
| Feb. 21, 2024 | Pelthos Therapeutics Inc. | $PTHS | Friedberg Ezra M | Director | P | Common Stock | 16667 | $6.00 | 545,721.0000 | 0 | 3.15% | 0.00% |
| Feb. 21, 2024 | Pelthos Therapeutics Inc. | $PTHS | Friedberg Ezra M | Director | M | Common Stock | 13649 | $4.80 | 513,727.0000 | 0 | 2.73% | 0.00% |
| Feb. 21, 2024 | Pelthos Therapeutics Inc. | $PTHS | Friedberg Ezra M | Director | M | Common Stock | 6992 | $4.80 | 520,719.0000 | 0 | 1.36% | 0.00% |
| Feb. 21, 2024 | Pelthos Therapeutics Inc. | $PTHS | Friedberg Ezra M | Director | C | Secured Convertible Promissory Note | 65514 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 21, 2024 | Pelthos Therapeutics Inc. | $PTHS | Friedberg Ezra M | Director | C | Secured Convertible Promissory Note | 33136 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |